Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 541096 | NSE Symbol : | ISIN : INE365Y01019 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
05-May-2025	12-May-2025	Accounts	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Board Meeting Intimation for the Quarter and Year ended on March 31 2025. Outcome of Board Meeting held on May 12, 2025. Appointment of Auditors. (As Per BSE Announcement Dated on: 12/05/2025)
15-Apr-2025	15-Apr-2025	Change in Other Executives	Intimation of Appointment of Company Secretary and compliance officer of the company.
23-Jan-2025	03-Feb-2025	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2025 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended on 31st December 2024 Unaudited standalone and consolidated Financial Results for the Quarter and nine months ended on 31st December,2024 (As Per BSE Announcement Dated on: 03/02/2025)
19-Oct-2024	29-Oct-2024	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2024 inter alia to consider and approve Intimation of Board meeting scheduled on 29th October 2024 to consider the unaudited Financial Result for quarter ended on 30th Sept. 2024 Financial Result for half year ended on 30th September, 2024 Intimation of Allotment of Equity shares 29th Oct, 24 and and re appointment of Mr. Bharat R. Desai, MD (As Per BSE Announcement dated on 29.10.2024)
31-Aug-2024	31-Aug-2024	Change in Auditors	Intimation for appointment of Statutory Auditor
31-Jul-2024	08-Aug-2024	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 inter alia to consider and approve Intimation of Board Meeting to be scheduled on 8th August 2024 for considering and approve unaudited Financial Result for Quarter Ended on 30th June 2024 Intimation of outcome of Board meeting for Standalone & consolidated Financial Result for quarter ended on 30th June, 2024. (As per BSE Announcement Dated on 08/08/2024) Intimation of Resignation of Statutory Auditor dated 10th August, 2024 (As Per BSE Announcement Dated on 10.08.2024)
06-Jun-2024	10-Jun-2024	Preferential Issue	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/06/2024 inter alia to consider and approve Intimation of Board Meeting Scheduled on 10th June 2024 in continuation of intimation filed dated 05th June 2024 for Allotment of Equity shares on Preferential Basis against Acquisition of Equity stake in Varenyam Healtcare Pvt & Varenyem Biolifesciences Pvt Ltd. Outcome of Board meeting held on 10th June, 2024 (As Per BSE Announcement Dated on: 10/06/2024)
26-May-2024	05-Jun-2024	Preferential Issue	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/06/2024 inter alia to consider and approve Intimation of Board Meeting as Scheduled on 5th June 2024 Intimation of Allotment of Equity Shares on Preferential Basis (As Per BSE Announcement Dated on:05/06/2024)
10-May-2024	22-May-2024	Accounts	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 inter alia to consider and approve To Consider and approve Audited Financial Resut (Standalone & Consolidated) of the company for Year ended on 31st March 2024 and quarterly result and other matters as may be approved by the chairman of the meeting Intimation of Board Meeting Scheduled on 22nd May, 2024 to consider and recommend Final Dividend for Financial Year ended on 31st March, 2024. (As Per BSE Announcement dated on 11.05.2024) Declaration of Financial Result for Quarter and Financial year ended on 31.03.2024 (As Per BSE Announcement Dated on 22.05.2024)
25-Apr-2024	29-Apr-2024	Preferential Issue	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (d) of SEBI LODR provision for Preferential Allotment of Equity Shares Outcome of Board meeting held 29th April, 2024 (As Per BSE Announcement Dated on 29.04.2024)
31-Jan-2024	13-Feb-2024	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve Board meeting for Adoption of unaudited Financial Statement for quarter ended on 31.12.2023 Financial Result Q3 (As Per BSE Announcement Dated on 13/02/2024)
01-Nov-2023	09-Nov-2023	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve To Consider unaudutied Financial Result & RPT transaction as on 30th September 2023 Board meeting outcome for unaudited Financial result- outcome of the Board Meeting held on 09.11.2023 (As Per BSE Announcement dated on 09.11.2023)
31-Aug-2023	31-Aug-2023	AGM	Outcome of the Board Meeting of the Company in its meeting held on Today i.e. Thursday, the 31st Day of August, 2023. The company has fixed record 25th September, 2023 for the purpose of determining the members eligible to receive the final dividend for the financial year 2022-23.
01-Aug-2023	09-Aug-2023	Quarterly Results	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve The unaudited financial results of the Company for the Quarter ended on June 30 2023. In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 09th August, 2023, has considered and approved the Unaudited Financial Results for the Quarter ended 30th June, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. (As Per BSE Announcement Dated on 09.08.2023)
06-May-2023	20-May-2023	Accounts	Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 inter alia to consider and approve we would like to inform you that in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 the meeting of Board of Directors of the Company is scheduled to be held on 20th May 2023 at the registered office of the Company situated at Survey No. 144-A Jarod Samlaya road Village Haripura. Ta. Savli Vadodara-391520 to consider and approve: 1. The Audited financial results of the Company for the Quarter and year ended on March 31st 2023. Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2023 ,inter alia, to consider and approve Update on board meeting (As Per BSE Announcement Dated on 19.05.2023) In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 20th May, 2023, has considered and approved the Audited Financial Results for the Quarter and year ended 31st March, 2023 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. The Board has also recommended payment of final dividend of Rs. 0.75 (Rupees Seventy-Five Paise Only) per Equity Share of Rs. 10/- each (fully paid-up) for the financial year ended March 31, 2023 and the same shall be payable subject to approval of the Shareholders at the ensuing Annual General Meeting ('AGM') of the Company. (As Per BSE Announcement dated on 20.05.2023) In compliance of Regulation 33(3)(d) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 (As per BSE Announcement Dated on 07/06/2023)

1 2

LOGIN HERE

Bharat Parenterals Ltd

Board Meeting